{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:28:19Z","timestamp":1788560899105,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.toxicon.2023.107087","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T02:06:22Z","timestamp":1678932382000},"page":"107087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["BoNT clinical trial update: Sialorrhea"],"prefix":"10.1016","volume":"226","author":[{"given":"Emily T.","family":"Tamadonfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.toxicon.2023.107087_bib1","first-page":"213","article-title":"A study of salivary secretion in Parkinson's disease","volume":"22","author":"Bagheri","year":"1999","journal-title":"Clin. Neuropharmacol."},{"issue":"14","key":"10.1016\/j.toxicon.2023.107087_bib2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000012573","article-title":"Placebo-controlled clinical trial of IncobotulinumtoxinA for sialorrhea in children: SIPEXI","volume":"97","author":"Berweck","year":"2021","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.toxicon.2023.107087_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-009-5144-0","article-title":"Debilitating consequences of drooling","volume":"256","author":"Bloem","year":"2009","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107087_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mds.22260","article-title":"Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease","volume":"24","author":"Evatt","year":"2009","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/j.toxicon.2023.107087_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/j.toxicon.2023.107087_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","article-title":"Safety and efficacy of RimabotulinumtoxinB for treatment of sialorrhea in adults: a randomized clinical trial","volume":"77","author":"Isaacson","year":"2020","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107087_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of sialorrhea with botulinum neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurology and Therapy"},{"issue":"17","key":"10.1016\/j.toxicon.2023.107087_bib8","doi-asserted-by":"crossref","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","article-title":"SIAXI: placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"Jost","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2023.107087_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2019.11.024","article-title":"Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks","volume":"70","author":"Jost","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/j.toxicon.2023.107087_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/ijms17060846","article-title":"Human saliva collection devices for proteomics: an update","volume":"17","author":"Khurshid","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107087_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"10.1016\/j.toxicon.2023.107087_bib12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.toxicon.2023.107087_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MOO.0b013e328011014a","article-title":"Drooling","volume":"14","author":"Lal","year":"2006","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107087_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/mdc3.12881","article-title":"Localization of salivary glands for botulinum toxin treatment: ultrasound versus landmark guidance","volume":"7","author":"Loens","year":"2019","journal-title":"Movement Disorders Clinical Practice"},{"issue":"6","key":"10.1016\/j.toxicon.2023.107087_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"10","key":"10.1016\/j.toxicon.2023.107087_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.12912","article-title":"Salivary secretory disorders, inducing drugs, and clinical management","volume":"12","author":"Miranda-Rius","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.toxicon.2023.107087_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419888601","article-title":"The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (xeomin(R))","volume":"12","author":"Morgante","year":"2019","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1016\/j.toxicon.2023.107087_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.parkreldis.2021.09.012","article-title":"Drooling rating scales in Parkinson's disease: a systematic review","volume":"91","author":"Nascimento","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/j.toxicon.2023.107087_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.parkreldis.2014.12.004","article-title":"Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients","volume":"21","author":"Ou","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/j.toxicon.2023.107087_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1176\/appi.neuropsych.11100315","article-title":"Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of life","volume":"24","author":"Ozdilek","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.toxicon.2023.107087_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.toxicon.2015.08.014","article-title":"Botulinum toxin A and B in sialorrhea: long-term data and literature overview","volume":"107","author":"Petracca","year":"2015","journal-title":"Toxicon : Official Journal of the International Society on Toxinology"},{"issue":"2","key":"10.1016\/j.toxicon.2023.107087_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mds.20189","article-title":"Salivary production in Parkinson's disease","volume":"20","author":"Proulx","year":"2005","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"9","key":"10.1016\/j.toxicon.2023.107087_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archoto.2009.110","article-title":"Surgical management of drooling: a meta-analysis","volume":"135","author":"Reed","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107087_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0194599820985165","article-title":"Surgical management of sialorrhea: a systematic review and meta-analysis","volume":"165","author":"Schild","year":"2021","journal-title":"Otolaryngology-Head Neck Surg. (Tokyo): Official Journal of American Academy of Otolaryngology-Head and Neck Surgery"},{"issue":"11","key":"10.1016\/j.toxicon.2023.107087_bib25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson's disease: a review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"12","key":"10.1016\/j.toxicon.2023.107087_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1469-8749.2012.04428.x","article-title":"Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities","volume":"54","author":"van Hulst","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107087_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00455-020-10102-5","article-title":"Drooling in Parkinson's disease: prevalence and progression from the non-motor international longitudinal study","volume":"35","author":"van Wamelen","year":"2020","journal-title":"Dysphagia"},{"key":"10.1016\/j.toxicon.2023.107087_bib28","article-title":"Salivation in Parkinson's disease: a scoping review","author":"Verhoeff","year":"2022","journal-title":"Gerodontology"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:52:35Z","timestamp":1736355155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":28,"alternative-id":["S0041010123000739"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107087","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BoNT clinical trial update: Sialorrhea","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107087"}}